Paula T Einhorn

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis
    Paula T Einhorn
    National Heart, Lung, and Blood Institute, Division of Epidemiology and Clinical Applications, Bethesda, MD 20892 7936, USA
    Am Heart J 153:42-53. 2007
  2. doi request reprint ALLHAT: still providing correct answers after 7 years
    Paula T Einhorn
    National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA
    Curr Opin Cardiol 25:355-65. 2010
  3. ncbi request reprint Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial
    Karen L Margolis
    HealthPartners Research Foundation PO Box 1524, Mailstop 21111R, Minneapolis, MN 55440 1524, USA
    Hypertension 50:854-61. 2007
  4. pmc Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Jackson T Wright
    Department of Medicine, General Clinical Research Center, Cleveland, Ohio, USA
    Arch Intern Med 168:207-17. 2008
  5. ncbi request reprint Action on racial disparity in hypertension control
    Paula T Einhorn
    Arch Intern Med 166:812. 2006
  6. doi request reprint Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute
    Barry L Carter
    Division of Clinical and Administrative Pharmacy, Rm 527, College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA
    Hypertension 52:30-6. 2008

Detail Information

Publications6

  1. ncbi request reprint The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis
    Paula T Einhorn
    National Heart, Lung, and Blood Institute, Division of Epidemiology and Clinical Applications, Bethesda, MD 20892 7936, USA
    Am Heart J 153:42-53. 2007
    ..However, questions have been raised regarding the validity of the HF diagnosis...
  2. doi request reprint ALLHAT: still providing correct answers after 7 years
    Paula T Einhorn
    National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA
    Curr Opin Cardiol 25:355-65. 2010
    ....
  3. ncbi request reprint Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial
    Karen L Margolis
    HealthPartners Research Foundation PO Box 1524, Mailstop 21111R, Minneapolis, MN 55440 1524, USA
    Hypertension 50:854-61. 2007
    ....
  4. pmc Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Jackson T Wright
    Department of Medicine, General Clinical Research Center, Cleveland, Ohio, USA
    Arch Intern Med 168:207-17. 2008
    ....
  5. ncbi request reprint Action on racial disparity in hypertension control
    Paula T Einhorn
    Arch Intern Med 166:812. 2006
  6. doi request reprint Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute
    Barry L Carter
    Division of Clinical and Administrative Pharmacy, Rm 527, College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA
    Hypertension 52:30-6. 2008